About 1 result found for searched term "Volociximab" (0.119 seconds)
Cat.No. | Name | Target |
---|---|---|
M58555 | Volociximab | Integrin |
M200 | ||
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.